Summary
This report documents the results of an integrated biochemical and immunocytochemical investigation into the expression of dystrophin (the protein product of the Duchenne muscular dystrophy gene) in muscle biopsies from 226 patients. It is the first study in which dystrophin has been analysed on blots and on tissue sections in such a large number of patients using the same (monoclonal) antibody. The 140 patients with Xp21 muscular dystrophy who were included in this study represent a continuous spectrum of disease severity and this range was reflected in the heterogeneity of dystrophin expression which was observed with respect to abundance, size and the pattern of tissue localisation. Approximately 40% of biopsies obtained from patients diagnosed as having Duchenne muscular, dystrophy (DMD) contained isolated clearly positive fibres and a further 20% had very weak labelling on a large number of fibres. Biopsies from patients with Becker muscular dystrophy (BMD) showed labelling patterns which varied from weak labelling on the majority of fibres to clear labelling on all fibres. Typically, however, there was inter-and intra-fibre variation in labelling intensity. Approximately 85% of the 52 BMD and 54 DMD patients who had unequivocal labelling on blots demonstrated a protein of abnormal size. The remaining 15% had a protein of normal size but reduced abundance. Overall, the estimated abundance of dystrophin correlated well with clinical assessments of the disease severity expressed in patients: We conclude that dystrophin analysis is an essential and dependable technique for the differential diagnosis of patients with Xp21 muscular dystrophy.
Similar content being viewed by others
References
Arahata K, Ishiura S, Ishiguro T, Tsukahara T, Suhara Y, Eguchi C, Ishihara T, Nonaka I, Ozawa E, Sugita H (1988) Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 333:861–863
Arahata K, Ishiura S, Tsukahara T, Sugita H (1989) Dystrophin digest. Nature 337: 606 (Addendum, to ref. 1)
Arahata K, Hoffman EP, Kunkel LM, Ishiura S, Tsukahara T, Ishihara T, Sunohara N, Nonaka I, Ozawa E, Sugita H (1989) Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses. Proc Natl Acad Sci USA 86:7154–7148
Arahata K, Ishihara T, Kamakura K, Tsukahara T, Ishiura S, Baba C, Matsumoto T, Nonaka I, Sugita H (1989) Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy. N Engl J Med 320: 138–142
Baumbach LL, Chamberlain JS, Ward PA, Farwell NJ, Caskey CT (1989) Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 39:465–474
Becker PE Kiener F (1955) Eine neue X-chromosomale Muskeldystrophie. Arch Psychiatr Z Neurol 193:427–448
Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, DiMauro S, Kunkel LM, Hoffman EP, Rowland LP (1988) Duchenne muscular dystrophy: deficiency of dystrophin at the muscular cell surface. Cell 54:447–452
Bonilla S, Schmidt B, Samitt CE, Miranda AF, Hays AP, De Oliveira ABS, Chang HW, Servidei S, Ricci E, Younger DS, DiMauro S (1988) Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne. Am J Pathol 133:440–445
Bradley WG, Jones MZ, Mussini JM, Fawcett PRW (1978) Becker-type muscular dystrophy. Muscle Nerve 1:111–132
Campbell KP, Kahl SD (1989) Association of dystrophin and an integral membrane glycoprotein. Nature 338:259–262
Dickson G, Pizzey JA, Elsom VE, Love D, Davies KE, Walsh FS (1988) Distinct dystrophin mRNA species are expressed in embryonic and adult mouse skeletal muscle. FEBS Lett 242:47–52
Den Dunnen JT, Grootscholten PM Bakker E, Blonden LAJ, Ginjaar HB, Wapenaar MC, van Paassen HMB, van Broeckhoven C, Pearson PL, van Ommen GJB (1989) Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 45:835–847
Duchenne GB (1868) Recherches sur la paralysie musculaire pseudohypertrophique ou paralysie myo-schlérosique. Arch Gen Med 11: 5–25, 170–209, 305–321, 421–443, 552–588
Emery AEH (1988) Duchenne muscular dystrophy, revised edn. Oxford monographs on medical genetics no. 15. Oxford University Press
Emery AEH, Skinner R (1976) Clinical studies in benign (Becker type) X-linked muscular dystrophy. Clin Genet 10:189–201
England S, Nicholson LVB, Johnson MA, Forrest SM, Love D, Zubrzycka-Gaarn E, Bulman DE, Harris JB, Davies KE (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343:180–182
Feener CA, Koenig M, Kunkel LM (1989) Alternative splicing of human dystrophin mRNA, generates isoforms, at the carboxy terminus. Nature 338:509–511
Gillard EF, Chamberlain JS, Murphy EG, Duff CL, Smith B, Burghes AHM, Thompson MW, Sutherland J, Oss I, Bodrug SE, Klamut HJ, Ray PN, Worton RG (1989) Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet 45:507–520
Goodman SR, Krebs KE, Whitfield CF, Riederer BM, Zagon IS (1988) Spectrin and related molecules. CRC Crit Rev Biochem 23:171–234
Hodgson S, Hart K, Abbs S, Heckmatt J, Rodillo E, Bobrow M, Dubowitz V (1989) Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. J Med Genet 26:682–693
Hoffman EP, Kunkel LM (1989) Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron 2:1019–1029
Hoffman EP, Brown RH, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919–928
Hoffman EP, Fischbeck KH Brown RH Johnson M, Medori R, Loike JD, Harris JB, Waterston R, Brooke M, Specht L, Kupsky W, Chamberlein J, Caskey T, Shapiro F, Kunkel LM (1988) Characterization of Dystrophin in muscle-biopsy speciments from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 318:1363–1368
Hoffman EP, Kunkel LM, Angelini C, Clarke A, Johnson M, Harris JB (1989) Improved diagnosis of Becker muscular dystrophy by dystrophin testing Neurology 39:1011–1017
Hoffman EP, Watkins SC, Slayter HS, Kunkel LM (1989) Detection of a specific isoform of alpha-actinin with antisera directed against dystrophin. J Cell Biol 108:503–510
Hori S, Sugiura H, Shimizu T, Hirabayashi T, Ohtani S, Yoshida M, Miyamoto K, Tanabe H (1989) Detection of dystrophin on two-dimentional gel electrophoresis. Biochem Biophys Res Commun 161:726–731
Kingston HM, Sarfarazi M, Thomas NST, Harper PS (1984) Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences. Hum Genet 67:6–17
Knudson CM, Hoffman EP, Kahl SD, Kunkel LM, Campbell KP (1988) Evidence for the association of dystrophin with the transverse tubular system in skeletal muscle. J Biol Chem 263:8480–8484
Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organisation of the DMD gene in normal and affected individuals. Cell 50:509–517
Koenig M, Monaco AP, Kunkel LM (1988) The complete sequence of dystrophin predicts a rod-shaped cryoskeletal protein. Cell 53:219–228
Koenig M plus 35 co-authors (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 45:498–506
Malhotra SB, Hart KA, Klamut HJ, Thomas NST, Bodrug SE, Burghes AHM, Bobrow M, Harper PS, Thompson MW, Ray PN, Worton RG (1988) Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242:755–759
Monaco AP Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM (1988) An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2:90–95
Muntoni F, Strong PN (1989) Transcription of the dystrophin gene in Duchenne muscular dystrophy muscle. FEBS Lett 252:95–98
Nicholson LVB, Davison K, Falkous G, Harwood C, O'Donnell E, Slater CR, Harris JB (1989) Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody. J Neurol Sci 94:125–136
Nicholson LVB, Davison K, Johnson MA, Slater CR, Young C, Bhattacharya S Gardner-Medwin D, Harris JB (1989b) Dystrophin in skeletal muscle. II. Immunoreactivity, in patients with Xp21 muscular dystrophy. J Neurol Sci 94: 137–146
Nordenskjöld M Nicholson LVB, Edström L, Anvret M, Eiserman M, Slater CR, Stolpe L (1990) A normal male with an inherited deletion, of one exon within the DMD gene. Hum Genet 84:207–209
Nudel U, Zuk D, Einat P, Zeelon E, Levy Z, Neuman S, Yaffe D (1989) Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature 337:76–78
Patel K, Voit T, Dunn MJ, Strong PN, Dubowitz V (1988) Dystrophin and nebulin in the muscular dystrophies. J Neurol Sci 87:315–326
Ryder-Cook AS, Sicinski P, Thomas K, Davies KE, Worton RG Barnard EA, Darlison MG, Barnard PJ (1988) Localization of the mdx mutation within the mouse dystrophin gene. EMBO Journal 7:3017–3021
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
Shimizu T, Matsumura K, Hashimoto K, Mannen T Ishiguro T, Eguchi C, Nonaka I, Yoshida M, Ozawa E (1988) A monoclonal antibody against a synthetic polypeptide fragment of dystrophin (amino acid sequence from position 215 to 264). Proc Jpn Acad 64:205–208
Walton JN, Gardner-Medwin D (1988) The muscular dystrophies. In: Walton JN (ed) Disorders of voluntary muscle, 5th edn. Churchill Livingstone, Edinburgh pp 519–568
Watkins SC, Hoffman ED, Slayter HS, Kunkel LM (1988) Immunoelectron microscopic localization of dystrophin in myofibres. Nature 333:863–866
Worton RG, Thompson MW (1988) Genetics of Duchenne muscular dystrophy. Annu Rev Genet 22:601–629
Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AHM, Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN, Worton RG (1988) The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333:466–469
Author information
Authors and Affiliations
Additional information
Supported by the University of Newcastle-upon-Tyne Research Committee, the Muscular Dystropy Group of Great Britain and the Medical Research Council
Rights and permissions
About this article
Cite this article
Nicholson, L.V.B., Johnson, M.A., Gardner-Medwin, D. et al. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol 80, 239–250 (1990). https://doi.org/10.1007/BF00294640
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00294640